1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanomamucosal melanomaActive, not recruitingPhase 22022-12-09NCT03241186